Lumida
/PHAT
⌘K
Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals Inc

PHAT
$8.36USD-0.12%-0.01 today

MARKET CAP

676.3M

P/E (TTM)

FWD P/E

DAY RANGE

$8 – $9

52W RANGE

$8
$18

AI Summary

Stalk
Sell NowMedium

Intermediate bearish pressure remains dominant for PHAT as price trades below declining EMAs with repeated rejection at moving average resistance, favoring selling into failed relief rallies around the 9/21/50 EMA confluence for tactical downside participation while acknowledging the longer-term uptrend.

  • Q4 2025 revenue of $57.6M rose 217% YoY, meeting guidance
  • Q2 2026 delivered positive operating profit ex-stock comp for first time
  • Full-year 2025 revenue of $175.1M masks ongoing profitability challenges
Full analysis →

Buying

5

institutions

Selling

10

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY4.53 M49.10 M+463.13 K+8.8%0.00%
MM

Millennium Management LLC

Q2 2026

SELL3.38 M36.63 M+-647.08 K-18.1%0.01%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW1.02 M11.09 M+1.02 M+0.0%0.01%
CA

Citadel Advisors LLC

Q2 2026

SELL696.80 K7.56 M+-221.36 K-25.9%0.00%
PA

Perceptive Advisors LLC

Q2 2026

SELL532.00 K5.77 M+-1.32 M-71.9%0.09%
WP

Woodline Partners LP

Q2 2026

SELL369.05 K4.00 M+-369.05 K-51.2%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

SELL275.25 K2.99 M+-12.18 K-1.1%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL226.40 K2.46 M+-79.40 K-27.7%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY134.90 K1.46 M+79.43 K+137.5%0.00%
MG

Man Group Plc

Q2 2026

BUY48.68 K528.17 K+18.33 K+56.6%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY43.00 K478.81 K+21.50 K+34.3%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL14.60 K158.40 K+-80.04 K-84.9%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL2.63 K28.52 K+-1.47 K-37.3%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL0.000.00+-95.30 K-100.0%0.00%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

SELL0.000.00+-84.00 K-100.0%0.00%